| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TSC complex subunit 1 | 0.440 | 0.808 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2006 | 2006 | ||||||||
|
TSC complex subunit 2 | 0.439 | 0.808 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2007 | 2007 | ||||||||
|
discoidin domain receptor tyrosine kinase 1 | 0.497 | 0.808 | 4.6E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
solute carrier family 7 member 5 | 0.513 | 0.808 | 0.24 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
itchy E3 ubiquitin protein ligase | 0.556 | 0.769 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 14 | 0.554 | 0.731 | 3.7E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
fibroblast growth factor 19 | 0.548 | 0.615 | 0.57 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
WW domain containing transcription regulator 1 | 0.529 | 0.615 | 0.94 |
|
disease | 0.030 | None | 0.333 | 3 | 0 | 2013 | 2020 | ||||||||
|
protein phosphatase 2 scaffold subunit Abeta | 0.678 | 0.423 | 3.0E-15 |
|
disease | 0.030 | None | 0.333 | 3 | 0 | 1999 | 2013 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.060 | None | 0.500 | 6 | 1 | 2000 | 2015 | ||||||||
|
folate receptor beta | 0.559 | 0.654 | 5.5E-06 |
|
disease | 0.040 | None | 0.500 | 4 | 0 | 2013 | 2019 | ||||||||
|
TNF receptor associated protein 1 | 0.590 | 0.615 | 1.6E-29 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2016 | 2016 | ||||||||
|
leukocyte immunoglobulin like receptor B1 | 0.510 | 0.769 | 5.7E-14 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2014 | 2015 | ||||||||
|
EPH receptor B4 | 0.524 | 0.692 | 1.3E-02 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2008 | 2008 | ||||||||
|
fibroblast growth factor receptor 4 | 0.490 | 0.769 | 7.2E-13 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2013 | 2015 | ||||||||
|
indoleamine 2,3-dioxygenase 1 | 0.454 | 0.846 | 3.3E-06 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2011 | 2017 | ||||||||
|
microRNA 211 | 0.552 | 0.577 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2015 | 2018 | |||||||||
|
microRNA 373 | 0.556 | 0.692 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2014 | 2016 | |||||||||
|
notch receptor 4 | 0.534 | 0.731 | 2.1E-23 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2016 | 2017 | ||||||||
|
ATR serine/threonine kinase | 0.456 | 0.923 | 3.5E-09 |
|
disease | 0.320 | None | 0.500 | 2 | 0 | 2005 | 2017 | ||||||||
|
DNA damage inducible transcript 4 | 0.576 | 0.769 | 6.8E-04 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2014 | 2018 | ||||||||
|
NLR family pyrin domain containing 2 | 0.515 | 0.731 | 1.4E-38 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2007 | 2017 | ||||||||
|
ADAM metallopeptidase domain 12 | 0.565 | 0.731 | 5.7E-07 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2015 | 2017 | ||||||||
|
SPARC like 1 | 0.604 | 0.615 | 5.6E-10 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2013 | 2018 |